- Filed
- May 7, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 5, 2020 | 56.93M sh |
| Long Term Debt | Q1 2020 · Mar 31, 2020 | $184.11M |
| Long Term Debt | Q1 2020 · Dec 31, 2019 | $178.25M |
| Short Term Debt | Q1 2020 · Mar 31, 2020 | $1.85M |
| Short Term Debt | Q1 2020 · Dec 31, 2019 | $1.85M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $16.3M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $13.35M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $74.21M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $75.02M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $269.02M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $264.9M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $34.13M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $28.41M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $415.3M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $412.72M |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 52.71M sh |
| Stock Repurchased | Q1 2020 · Mar 31, 2019 | $1.34M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | −$417K |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | $52.14M |
| Stockholders Equity | Q1 2020 · Dec 31, 2018 | $60.95M |
| Eps Diluted restated | Q1 2020 · Mar 31, 2019 | −$170.00 |
| Eps Basic restated | Q1 2020 · Mar 31, 2019 | −$170.00 |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $20.26M |
| Rd Expense | Q1 2020 · Mar 31, 2019 | $4.15M |
| Net Income | Q1 2020 · Mar 31, 2019 | −$6.27M |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$6.25M |
| Gross Profit | Q1 2020 · Mar 31, 2019 | $18.16M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $11.14M |
| Revenue | Q1 2020 · Mar 31, 2019 | $29.3M |